Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEI; Angiotensin converting enzyme inhibitors; ARB; Angiotensin receptor blocker; BP; Blood pressure; CCB; Calcium channel blocker; CHD; Coronary heart disease; CKD; Chronic kidney disease; CPGs; Clinical practice guidelines; CV; Cardiovascular; DHP-CCB;
مقالات ISI مهارکننده آنزیم تبدیلکننده آنژیوتانسین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; AA; African American; Alb; albumin; ACE; Angiotensin converting enzyme; ACEI; Angiotensin converting enzyme inhibitor; ARB; Angiotensin II receptor blocker; CNI; Calcineurin inhibitor; CAU; Caucasian; CAN; Chronic allograft nephropathy; CKD; Chronic kidne
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; AAD; antiarrhythmic drug; ACEi; angiotensin-converting enzyme inhibitor; AF; atrial fibrillation; AFFIRM; Atrial Fibrillation Follow-up Investigation of Rhythm Management; ARB; angiotensin receptor blocker; ARIC; Analysis of the Atherosclerosis Risk in Co
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; HTN; Hypertension or hypertensive; CVD; Cardiovascular disease; BP; Blood pressure; LV; Left ventricular or left ventricle; DM; Diabetes mellitus; LVM; Left ventricular mass; RWT; Relative wall thickness; CR; Concentric remodeling; LVH; Left ventricular h
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ABPM; ambulatory blood pressure monitoring; ACEI; angiotensin-converting enzyme inhibitor; ARB; angiotensin II receptor blocker; BP; blood pressure; CKD; chronic kidney disease; HBPM; home BP monitoring; HTN; hypertension; JNC-7; Seventh Joint National Co
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACE; angiotensin-converting enzyme; ACEI; angiotensin-converting enzyme inhibitor; AMR; analytical measurement range; CPOE; computerized provider order entry; EDTA; ethylenediaminetetraacetic acid; EHR; electronic health record; LC-TOF-MS; liquid chromato
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ABPM; ambulatory blood pressure monitoring; ACEi; angiotensin converting enzyme inhibitors; ARB; angiotensin II receptor blockers; BMI; body mass index; BP; blood pressure; CKD; chronic kidney disease; CRF; case-report form; ENTRED; Echantillon National T
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; NAFLD; non-alcoholic fatty liver disease; IHTG; intrahepatic triglyceride; BMI; body mass index; SBP; systolic blood pressure; DBP; diastolic blood pressure; FPG; fasting plasma glucose; HOMA-IR; homeostasis model assessment of insulin resistance; TG; tri
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEI; angiotensin-converting enzyme inhibitor; AMS; altered mental status; ARDS; acute respiratory distress syndrome; BAL; bronchoalveolar lavage; BO; bronchiolitis obliterans; CAP; community-acquired pneumonia; COPD; chronic obstructive pulmonary disease
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEi; angiotensin-converting enzyme inhibitor; AF; atrial fibrillation; A-II; angiotensin-II; ANP; atrial natriuretic peptide; ARB; angiotensin receptor blocker; BP; blood pressure; BMI; body mass index; BNP; brain natriuretic peptide; CaMKII; calmodulin-
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; AAD; antiarrhythmic drug; ACEI; angiotensin-converting enzyme inhibitor; AF; atrial fibrillation; AFL; atrial flutter; ARB; angiotensin II receptor blocker; COPD; chronic obstructive pulmonary disease; CS; coronary sinus; CTI; cavotricuspid isthmus; HATCH
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; AA; arachidonic acid; ACS; acute coronary syndrome; ACEI; angiotensin-converting enzyme inhibitor; ADP; adenosine 5â²-diphosphate; AMI; acute myocardial infarction; ARBs; angiotensin receptor blockers; AUC; areas under the curve; BMI; body mass index; CA
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; Renin-angiotensin system - RAS; Lipid metabolism; Glucose metabolism; ACEi; ARBs;
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; AA; arachidonic-acid; ACEI; angiotensin-converting-enzyme inhibitor; ACS; acute coronary syndrome; ADP; adenosine-diphosphate; ARB; angiotensin-II receptor blocker; BMI; body mass index; CABG; coronary artery bypass graft; CAD; coronary artery disease; CO
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; NCEP; National Cholesterol Education Program; ATP; Adult Treatment Panel; MetS; metabolic syndrome; ACEI; angiotensin converting enzyme inhibitor; ARB; angiotensin receptor blocker; CHS; Cardiovascular Health Study; NHLBI; National Heart Lung and Blood In
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEI; angiotensin-converting enzyme inhibitor; NHI; National Health Insurance;
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; RAS; renin-angiotensin system; Ang II; angiotensin II; AT1R; angiotensin receptor type 1; AT2R; angiotensin receptor type 2; ACE; angiotensin converting enzyme; ACE2; angiotensin converting enzyme 2; Ang-(1-7); angiotensin-(1-7); ARB; angiotensin re
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEI; angiotensin converting enzyme inhibitor; ARB; angiotensin II receptor blockers; ASD; atrial septal defect; CI; confidence interval; ECG; electrocardiography; HR; hazard ratio; LV; left ventricular; Pd; P-wave dispersion; Qp/Qs ratio; ratio of pulmon
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; AF; atrial fibrillation; MetS; metabolic syndrome; DM; diabetes mellitus; LAD; left atrial diameter; LVEF; left ventricular ejection fraction; ARB; angiotensin II receptor blockers; ACEI; angiotensin-converting enzyme inhibitor; LRAF; late recurrence of A
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; cost-effectiveness; heart failure; medications; ACEI; angiotensin-converting enzyme inhibitor; AldA; aldosterone antagonists; BB; beta-blocker; HF; heart failure; HFrEF; heart failure with reduced ejection fraction; ICER; incremental cost-effectiveness ra
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; Mast cell; Atherosclerosis; Restenosis; Aneurysm; Vein graft; Vascular remodeling; 5-LO; 5-lipoxygenase; AAA; abdominal aortic aneurisma; ABCA1; ATP-binding cassette transporter A1; ACE; angiotensin converting enzyme; ACEI; angiotensin converting enzyme i
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEI; angiotensin converting-enzyme inhibitors; CCG; cationic colloidal gold; EM; electron microscopy; GAG; glycosaminoglycan; GBM; glomerular basement membrane; HS; heparan sulfate; HSPG; heparan sulfate proteoglycans; PAN; puromycinaminonucleoside; RAS;
Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; AF; atrial fibrillation; ACEI; angiotensin converting enzyme inhibitor; AF-HTN; atrial fibrillation hypertensive; AF-NT; atrial fibrillation normotensive; ARB; angiotensin receptor blocker; BP; blood pressure; CV; cardiovascular; EORP-AF; EURObservational
PXR polymorphisms have impact on the clinical efficacy of clopidogrel in patients undergoing percutaneous coronary intervention
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ABCB1; ATP-binding cassette, sub-family B, member 1; ACEI; angiotensinconverting enzyme inhibitor; ADP; adenosine diphosphate; ARB; angiotensin receptor blocker; CCB; calcium channel blockers; CHD; Coronary Heart Disease; CLP; clopidogrel; CLPM; clopidogr
Novel approaches in the treatment of diabetic cardiomyopathy
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACE; angiotensin convertase enzyme; ACEi; angiotensin convertase enzyme inhibitor; ADP; adenosine di phosphate; AGE; advanced glycation end products; AM; adrenomedullin; AMP; adenosine mono phosphate; ARB; angiotensin receptor blocker; ATP; adenosine tri
Effects of acid hydrolysis on the free radical scavenging capacity and inhibitory activity of the angiotensin converting enzyme of phenolic compounds of two varieties of jamaica (Hibiscus sabdariffa)
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; Hibiscus sabdariffa; Acid hydrolysis; Flavonoids; FRSC; ACEI;
Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEI; angiotensin converting enzyme inhibitor; AHF; acute heart failure; ARB; angiotensin receptor blocker; ARNI; angiotensin receptor-neprilysin inhibitor; CKD; chronic kidney disease; GFR; glomerular filtration rate; HFpEF; heart failure with preserved
Redox signal-mediated TRPM2 promotes Ang II-induced adipocyte insulin resistance via Ca2+-dependent CaMKII/JNK cascade
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; TRPM2; transient receptor potential melastatin 2; Ang II; angiotensin II; H2O2; hydrogen peroxide; ADPR; ADP-ribose; ACA; N-(p-amylcinnamoyl)anthranilic acid; NAC; N-acetylcysteine; RAS; renin-angiotensin system; AT1R; Ang II type 1 receptor blocker; ACEI
Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; Hereditary angioedema; Normal C1 inhibitor; F12 mutations; Estrogen; Brazilian population; ACEI; Angiotensin-converting enzyme inhibitor; C1-INH; C1 inhibitor; C1-INH-HAE; Hereditary angioedema with C1 inhibitor deficiency; eOC; Estrogen-containing oral c
Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; Renin-angiotensin system; Epithelial-to-mesenchymal transition; Kidney proximal tubular epithelial cells; Renal fibrosis; Alismatis rhizoma; 25-O-methylalisol F; ACE; renin, angiotensin-converting enzyme; ACEI; angiotensin-converting enzyme inhibitors; AG
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; death; diabetes mellitus; heart failure; observational studies; sodium glucose cotransporter-2 inhibitors; SGLT-2 inhibitor; ACD; all-cause death; ACEi; angiotensin converting enzyme inhibitor; ARB; angiotensin receptor blocker; CI; confidence interval; C
Evolution of Functional Mitral Regurgitation and Prognosis in Medically Managed Heart Failure Patients With Reduced Ejection Fraction
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; functional mitral regurgitation; heart failure; medical management; ACEI; angiotensin-converting enzyme inhibitor; AHT; arterial hypertension; ARB; angiotensin receptor blocker; CRT; cardiac resynchronization therapy; FMR; functional mitral regurgitation
Reverse J-Curve Relationship Between On-Treatment Blood Pressure and Mortality in Patients With Heart Failure
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; blood pressure; heart failure; heart failure with reduced ejection fraction; heart failure with preserved ejection fraction; J-curve; mortality; AA; aldosterone antagonist; ACEI; angiotensin-converting enzyme inhibitor; ANOVA; 1-way analysis of variance m
Corydalis hendersonii Hemsl. protects against myocardial injury by attenuating inflammation and fibrosis via NF-κB and JAK2-STAT3 signaling pathways
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; AA; arachidonic acid; ACEI; angiotensin converting enzyme inhibitor; ADP; adenosine 5-diphosphate; AMI; acute myocardial infarction; AngII; angiotensin II; CH; Corydalis hendersonii Hemsl.; CK-MB; creatine kinase-MB; EF; ejection fraction; FS; fractional
Imaging-Guided Cardioprotective Treatment in a Community Elderly Population of Stage B Heart Failure
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; community detection; medication nonadherence; pharmacological intervention; randomized controlled trial; stage B heart failure; A; peak late diastolic velocity; ACEi; angiotensin-converting enzyme inhibitor; AE; advanced echocardiography arm; AF; atrial f
Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; angiotensin II; angiotensin-(1-7); chymase; dilated cardiomyopathy; renin-angiotensin system; ACE; angiotensin-converting enzyme; ACEI; angiotensin-converting enzyme inhibitor; AHF; acute heart failure; Ang I; angiotensin-(1-10); Ang II; angiotensin-(
Pediatric Fontan patients are at risk for myocardial fibrotic remodeling and dysfunction
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEi; angiotensin converting enzyme inhibitor; BCPC; bicavopulmonary connection; CMR; cardiac magnetic resonance; ECV; extracellular volumes; EF; ejection fraction; FT; feature-tracking; LGE; late gadolinium enhancement; LV; left ventricle; MOLLI; modifie
Moving pieces in a cryptomic puzzle: Cryptide from Tityus serrulatus Ts3 Nav toxin as potential agonist of muscarinic receptors
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACE; angiotensin-converting enzyme; ACEi; angiotensin-converting enzyme inhibitor; ACh; acetylcholine; BK; bradykinin; BPP; bradykinin-potentiating peptide; Hip; N-hippuryl; mAChR; muscarinic acetylcholine receptor; NO; nitric oxide; NOS; nitric oxide syn
Association between plasma soluble RAGE and renal function is unaffected by medication usage and enzymatic antioxidants in chronic kidney disease with type 2 diabetes
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; CKD; chronic kidney disease; D-CKD; diabetic CKD; ND-CKD; non-diabetic CKD; DM; diabetic patients without CKD; Non-DM; patients without diabetes and CKD; eGFR; estimated glomerular filtration rate; GPx; glutathione peroxidase; SOD; superoxide dismutase; R
Kidney Disease Progression in Autosomal Recessive Polycystic Kidney Disease
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; A/H/D; Aplastic/hypoplastic/dysplastic disorder; ACEI; Angiotensin-converting enzyme inhibitor; ARPKD; Autosomal recessive polycystic kidney disease; CKD; Chronic kidney disease; CKiD; Chronic Kidney Disease in Children; CT; Collecting tubule; eGFR; Estim
The kinetics of angiotensin-I metabolism in human carotid atheroma: An emerging role for angiotensin (1-7)
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEi; angiotensin converting enzyme inhibitor; AGT; Angiotensinogen; Ang; angiotensin-; AT1R; angiotensin-II type 1 receptor; AT2R; angiotensin-II type 2 receptor; ARB; AT1R blocker; ATH; advanced atheroma; MasR; Mas1 receptor; MIT; macroscopically intact
Sodium intake, RAAS-blockade and progressive renal disease
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEi; angiotensin converting enzyme inhibitor; ARB; angiotensin receptor blocker; CKD; chronic kidney disease; NFAT5; nuclear factor of activated T cells 5; RAAS; renin-angiotensin-aldosterone system; SGK1; serum/glucocorticoid-regulated kinase 1; Th17 ce
Generalizability of SPRINT Results to the U.S. Adult Population
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; control; hypertension; population health; systolic blood pressure; treatment; ACEI; angiotensin-converting enzyme inhibitors; BMI; body mass index; CHD; coronary heart disease; DBP; diastolic blood pressure; eGFR; estimated glomerular filtration rate; SBP
H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEI; Angiotensin-converting enzyme inhibitors; CBS; cystathionine β-synthase; COX-2; cyclooxygenase-2; CSE; cystathionine gamma-lyase; eNOS; endothelial NO synthase; H2S; hydrogen sulfide; HUASM; human umbilical artery smooth muscle cells; HUVEC; human
Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; Diabetic kidney disease; Diabetic nephropathy; Urinary sediment; Beta-2-microglobulin; Focal segmental glomerulosclerosis; ACEI; (angiotensin converting enzyme inhibitors); ACR; (albumin-to-creatinine ratio); AGE; (advanced glycation end products); ARB; (
“Observational Medicine” should be replaced by “Real Science”
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; Statins; HMG-CoA reductase inhibitors; EECP; Enhanced Extracorporeal Counterpulsation; ACEI; angiotensin-converting-enzyme inhibitor;
Exaggerated hypertensive response to combretastatin A-4 phosphate in hypertensive rats: Effective pharmacological inhibition by diltiazem
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEI; angiotensin converting enzyme inhibitor; CA4P; Combretastatin A-4 phosphate; DSS; Dahl salt sensitive; HS; high salt; MAP; mean arterial blood pressure; ND; normal low salt diet; Anticancer agents; Blood pressure; Calcium channel blockers; Cardiac t
Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBaseâ¢
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACEI; angiotensin converting enzyme inhibitor; ADE; adverse drug events; AERS; adverse event reporting system; APAP; acetaminophen; ATC classification; Anatomical Therapeutic Chemical Classification; ATIIA; angiotensin II receptor antagonist; BSEP; bile s
Comparing LCZ696 With Enalapril According to Baseline Risk Using the MAGGIC and EMPHASIS-HF Risk Scores: An Analysis of Mortality and Morbidity in PARADIGM-HF
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; angiotensin receptor neprilysin inhibitor; prognostic model; risk score; survival; ACEI; angiotensin-converting enzyme inhibitor; AF; atrial fibrillation; ARB; angiotensin receptor blocker; BMI; body mass index; BNP; B-type natriuretic peptide; eGFR; esti
Challenges and solutions in medically managed ACS in the Asia-Pacific region: Expert recommendations from the Asia-Pacific ACS Medical Management Working Group
Keywords: مهارکننده آنزیم تبدیلکننده آنژیوتانسین; ACACIA; Australian Acute Coronary Syndromes Prospective Audit; ACCORD; ACute CORonary syndromes Descriptive study; ACCF; American College of Cardiology Foundation; ACEi; angiotensin-converting enzyme inhibitor; ACS; acute coronary syndromes; ADPi; adenosi